您好,欢迎来到魔法化学网!
合作交流
|
服务时间(9:30-18:00)
百科
百科
▼
百科
资讯
搜索
结构式
乙二醇
甲醛
63148-62-9
MDI
丁酮
二甲基亚砜
碳酸氢钠
471-34-1
首页
化合物百科
价格行情
资讯
化工导航
实验室工具
搜索
乙二醇
甲醛
63148-62-9
MDI
丁酮
二甲基亚砜
碳酸氢钠
471-34-1
Selinexor
合成路线
(共 5 条)
1388842-44-1
+
54608-52-5
吡嗪-2-肼
→
反应条件
1393477-72-9
Selinexor
反应条件
1-propanephosphonic acid cyclic anhydride; N-ethyl-N,N-diisopropylamine in dichloromethane; ethyl acetate T=-40°C; 0.5 h;
参考文献
KARYOPHARM THERAPEUTICS, INC.; SANDANAYAKA, Vincent, P.; SHACHAM, Sharon; MCCAULEY, Dilara; SHECHTER, Sharon
Patent: WO2013/19548 A1, 2013 ;
Location in patent: Page/Page column 56-57 ;
WO 2013/019548 A1
1333154-10-1
→
反应条件
1393477-72-9
Selinexor
反应条件
1.1: 1,4-diaza-bicyclo[2.2.2]octane / N,N-dimethyl-formamide / 0.5 h 1.2: 1 h 2.1: lithium hydroxide hydrate; water / tetrahydrofuran / 4 h / 20 °C 3.1: 1-propanephosphonic acid cyclic anhydride; N-ethyl-N,N-diisopropylamine / dichloromethane; ethyl acetate / 0.5 h / -40 °C View Scheme
参考文献
KARYOPHARM THERAPEUTICS, INC.; SANDANAYAKA, Vincent, P.; SHACHAM, Sharon; MCCAULEY, Dilara; SHECHTER, Sharon
Patent: WO2013/19548 A1, 2013 ;
WO 2013/019548 A1
27126-93-8
3,5-双三氟甲基苯腈
→
反应条件
1393477-72-9
Selinexor
反应条件
1.1: NaHS monohydrate / N,N-dimethyl-formamide / 0.42 h / 10 °C / |Inert atmosphere; |Large scale 1.2: 0.83 h / 10 °C / |Large scale 2.1: hydrazine hydrate / N,N-dimethyl-formamide / 2 h / 10 °C / |Inert atmosphere; |Large scale 2.2: 13 h / 0 - 100 °C / |Large scale 3.1: 1,4-diaza-bicyclo[2.2.2]octane / N,N-dimethyl-formamide / 0.5 h 3.2: 1 h 4.1: lithium hydroxide hydrate; water / tetrahydrofuran / 4 h / 20 °C 5.1: 1-propanephosphonic acid cyclic anhydride; N-ethyl-N,N-diisopropylamine / dichloromethane; ethyl acetate / 0.5 h / -40 °C View Scheme
参考文献
KARYOPHARM THERAPEUTICS, INC.; SANDANAYAKA, Vincent, P.; SHACHAM, Sharon; MCCAULEY, Dilara; SHECHTER, Sharon
Patent: WO2013/19548 A1, 2013 ;
WO 2013/019548 A1
317319-15-6
3,5-二(三氟甲基)硫代苯甲酰胺
→
反应条件
1393477-72-9
Selinexor
反应条件
1.1: hydrazine hydrate / N,N-dimethyl-formamide / 2 h / 10 °C / |Inert atmosphere; |Large scale 1.2: 13 h / 0 - 100 °C / |Large scale 2.1: 1,4-diaza-bicyclo[2.2.2]octane / N,N-dimethyl-formamide / 0.5 h 2.2: 1 h 3.1: lithium hydroxide hydrate; water / tetrahydrofuran / 4 h / 20 °C 4.1: 1-propanephosphonic acid cyclic anhydride; N-ethyl-N,N-diisopropylamine / dichloromethane; ethyl acetate / 0.5 h / -40 °C View Scheme
参考文献
KARYOPHARM THERAPEUTICS, INC.; SANDANAYAKA, Vincent, P.; SHACHAM, Sharon; MCCAULEY, Dilara; SHECHTER, Sharon
Patent: WO2013/19548 A1, 2013 ;
WO 2013/019548 A1
1333152-22-9
→
反应条件
1393477-72-9
Selinexor
反应条件
1: lithium hydroxide hydrate; water / tetrahydrofuran / 4 h / 20 °C 2: 1-propanephosphonic acid cyclic anhydride; N-ethyl-N,N-diisopropylamine / dichloromethane; ethyl acetate / 0.5 h / -40 °C View Scheme
参考文献
KARYOPHARM THERAPEUTICS, INC.; SANDANAYAKA, Vincent, P.; SHACHAM, Sharon; MCCAULEY, Dilara; SHECHTER, Sharon
Patent: WO2013/19548 A1, 2013 ;
WO 2013/019548 A1